Six minutes walk test for individuals with schizophrenia

Disability and Rehabilitation

Volumn 37, Issue 11, 2015, Pages 921-927

  Bernard, P ^a   Romain, A J ^a   Vancampfort, D ^b   Baillot, A ^c   Esseul, E ^d   Ninot, G ^a  

^a University of Montpellier   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d St Clement Clinic   (France)

Author keywords

6 minute walk test; Exercise; Functional capacity; Physical health; Schizophrenia

Indexed keywords

ADULT; EXERCISE TEST; FEMALE; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; REPRODUCIBILITY; SCHIZOPHRENIA; SELF CONCEPT; WALKING;

ADULT; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SELF CONCEPT; WALKING;

EID: 84928122316     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2014.948136     Document Type: Review

References (49)

1. Enright PL. The six-minute walk test. Resp Care 2003;48:783-5.
2. ATS. ATS statement: guidelines for the six-minute walk test. Am J Resp Crit Care Med 2002;166:111-17.
3. Hulens M, Vansant G, Claessens AL, et al. Predictors of 6-minute walk test results in lean, obese and morbidly obese women. Scand J Med Sci Sp 2003;13:98-105.
4. Pankoff B, Overend T, Lucy S, et al. Reliability of the six-minute walk test in people with fibromyalgia. Arthritis Care Res 2000;13: 291-5.
5. Olsson LG, Swedberg K, Clark AL, et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-93.
6. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Resp J 1999;14:270-4.
7. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Resp Crit Care Med 2000;161:487-92.
8. Rasekaba T, Lee AL, Naughton MT, et al. The six-minute walk test: a useful metric for the cardiopulmonary patient. Inter Med J 2009; 39:495-501.
9. Avouac J, Kowal-Bielecka O, Pittrow D, et al. Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group. Ann Rheu Dis 2010;69:1360-3.
10. De Feo S, Tramarin R, Lorusso R, et al. Six-minute walking test after cardiac surgery: instructions for an appropriate use. Eur J Cardio Prev Rehab 2009;16:144-9.
11. Savarese G, Paolillo S, Costanzo P, et al. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials. J Am Coll Card 2012;60:1192-201.
12. Vancampfort D, Probst M, Sweers K, et al. Reliability, minimal detectable changes, practice effects and correlates of the 6-min walk test in patients with schizophrenia. Psychiatry Res 2011;187:62-7.
13. Marder SR, Essock SM, Miller, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004;161:1334-49.
14. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007;(1): CD005148. doi: 10.1002/14651858.CD005148.pub2.
15. Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patientreported outcomes. J Clin Epidemiol 2010;63:737-45.
16. Casanova C, Celli BR, Barria P, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Resp J 2011;37:150-6.
17. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Pub; 2000.
19. Archie S, Wilson JH, Osborne S, et al. Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry 2003;48:628-32.
20. Fogarty M, Happell B, Pinikahana J. The benefits of an exercise program for people with schizophrenia: a pilot study. Psychiatr Rehabil J 2004;28:173-6.
21. Beebe L, Tian L, Morris N, et al. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005;26:661-76.
22. Hackney ME, Earhart G. Social partnered dance for people with serious and persistent mental illness: a pilot study. J Nerv Ment Dis 2010;198:76-8.
23. Marzolini S, Jensen B, Melville P. Feasibility and effects of a groupbased resistance and aerobic exercise program for individuals with severe schizophrenia: a multidisciplinary approach. Ment Health Phys Act 2009;2:29-36.
24. Dodd KJ, Duffy S, Stewart JA, et al. A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: a pilot study. Disabil Rehabil 2010;33:1222-9.
25. Vancampfort D, Probst M, Sweers K, et al. Relationships between obesity, functional exercise capacity, physical activity participation and physical selfperception in people with schizophrenia. Acta Psychiatr Scand 2011;123:423-30.
26. Vancampfort D, Probst M, Scheewe T, et al. Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia. Schizophr Res 2011; 129:122-7.
27. Vancampfort D, Probst M, De Herdt A, et al. An impaired health related muscular fitness contributes to a reduced walking capacity in patients with schizophrenia: a cross-sectional study. BMC Psychiatry 2013;13:5.
28. Vancampfort D, De Herdt A, Sweers K, et al. Diabetes, physical activity participation and exercise capacity in patients with schizophrenia. Psychiatry Clin Neurosci 2013;67:451-6.
29. Vancampfort D, Sweers K, Probst M, et al. Association of the metabolic syndrome with physical activity performance in patients with schizophrenia. Diabetes Metab 2011;37:318-23.
30. Hansson L, Middelboe T, Merinder L, et al. Predictors of subjective quality of life in schizophrenic patients living in the community. A Nordic Multicentre Study. Int J Soc Psychiatry 1999; 45:247-58.
31. Weinberg D, Shahar G, Noyman G, et al. Role of the self in schizophrenia: a multidimensional examination of short-term outcomes. Psychiatry Interp Biol Proc 2012;75:285-97.
32. Vancampfort D, Hert MD, Maurissen K, et al. Physical activity participation, functional exercise capacity and self-esteem in patients with schizophrenia. Int J Therapy Rehabil 2011;18:222-30.
33. Martń-Sierra A, Vancampfort D, Probst T, et al. Walking capacity is associated with health related quality of life and physical activity level in patients with schizophrenia: a preliminary report. Actas Espanõlas Psiquiatrá 2011;39:211-16.
34. Vancampfort D, Probst M, Scheewe T, et al. The functional exercise capacity is correlated with global functioning in patients with schizophrenia. Acta Psychiatry Scand 2012;125:382-7.
35. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemol 1999;52:861-73.
36. Daumit G, Dalcin AT, Jerome GJ, et al. A behavioral weightloss intervention for persons with serious mental illness in psychiatric rehabilitation centers. Int J Obesity 2010;35:1114-23.
37. Heggelund J, Nilsberg GE, Hoff J, et al. Effects of high aerobic intensity training in patients with schizophrenia-a controlled trial. Nord J Psychiatry 2011;65:269-75.
38. Abdel-Baki A, Brazzini-Poisson V, Marois F, et al. Effects of aerobic interval training on metabolic complications and cardiorespiratory fitness in young adults with psychotic disorders: a pilot study. Schizophr Res 2013;149:112-15.
39. Nilsson BM, Olsson RM, Oman, et al. Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls. Eur Psychiatry 2012;27:206-12.
40. Heggelund J, Hoff J, Helgerud J, et al. Reduced peak oxygen uptake and implications for cardiovascular health and quality of life in patients with schizophrenia. BMC Psychiatry 2011;11:188.
41. Putzhammer A, Heindl B, Broll K, et al. Spatial and temporal parameters of gait disturbances in schizophrenic patients. Schizophr Res 2004;69:159-66.
42. Pitta F, Troosters T, Spruit MA, et al. (2005). Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2004;171:972-7.
43. Hofer A, Hummer M, Huber R, et al. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol 2000, 20: 699-702.
44. Larsson U, Reynisdottir S. The six-minute walk test in outpatients with obesity: reproducibility and known group validity. Physiol Res Inter 2008;13:84-93.
45. Olczyk J, Kokoszko A, Lewiński A, et al. Quality of life and exercise capacity in obesity and growth hormone deficiency. Neuro Endocrinol Lett 2010;31:700-7.
46. Pires SR, Oliveira AC, Parreira VF, et al. Six-minute walk test at different ages and body mass indexes. Braz J Phys Ther 2007;11: 131-4.
47. Mathai SC, Puhan MA, Lam D, et al. The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Resp Crit Care Med 2012;186: 428-33.
48. Sciurba F, Criner G, Lee S, Mohsenifar Z, et al. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Resp Crit Care Med 2003;167:1522-7.
49. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407.